Silk Road Medical, Inc (SILK)
NASDAQ: SILK · IEX Real-Time Price · USD
27.07
+0.02 (0.07%)
At close: Jul 19, 2024, 4:30 PM
27.19
+0.12 (0.44%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Silk Road Medical Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Silk Road Medical stock have an average target of 21.14, with a low estimate of 8.00 and a high estimate of 30. The average target predicts a decrease of -21.91% from the current stock price of 27.07.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SILK stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 2 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 6 | 5 | 5 | 5 | 6 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Total | 12 | 12 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy → Hold Downgrades $23 → $28 | Strong Buy → Hold | Downgrades | $23 → $28 | +1.59% | Jul 17, 2024 |
| Argus Research | Argus Research | Strong Buy → Strong Sell Downgrades n/a | Strong Buy → Strong Sell | Downgrades | n/a | n/a | Jul 11, 2024 |
| Lake Street | Lake Street | Strong Buy → Hold Downgrades $28 → $28 | Strong Buy → Hold | Downgrades | $28 → $28 | +1.59% | Jun 18, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | -22.42% | May 1, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | -26.12% | May 1, 2024 |
Financial Forecast
Revenue This Year
201.67M
from 177.13M
Increased by 13.85%
Revenue Next Year
224.60M
from 201.67M
Increased by 11.37%
EPS This Year
-1.46
from -1.44
EPS Next Year
-1.36
from -1.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 211.1M | 236.7M | 264.7M |
| Avg | 201.7M | 224.6M | 247.9M |
| Low | 190.8M | 211.5M | 232.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 19.1% | 17.4% | 17.9% |
| Avg | 13.9% | 11.4% | 10.4% |
| Low | 7.7% | 4.9% | 3.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.43 | -1.28 | -1.12 |
| Avg | -1.46 | -1.36 | -1.26 |
| Low | -1.49 | -1.43 | -1.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.